Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Newormics
Newormics is a developer of the first high-throughput, high-content drug screening platforms for use with in vivo small animal models as well as in vitro 3D tissue constructs. The company provides…
Newormics
Newormics is a developer of the first high-throughput, high-content drug screening platforms for use with in vivo small animal models as well as in vitro 3D tissue constructs. The company provides…
TL;DR
Founded: 2016
Industry: Biotechnology
Product focus: Microfluidics-based high-throughput in vivo and 3D in vitro drug/toxicity screening
Rebrand / aka: Operates as vivoVerse (formerly Newormics LLC)
Headcount (approx.): 12
Company Overview
Problem Domain
Early-stage drug discovery and toxicology/safety testing where higher-throughput, lower-cost in vivo and 3D in vitro assays are needed.
Founded
2016
Industry
Biotechnology
Funding Track Record
Investor Signal
“MassChallenge listed as an investor or supporter”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week